Receipt of Requisition Notice

Pharma C Investments PLC

23 August 2023

 

23 August 2023

Receipt of Requisition Notice

Pharma C Investments Plc ("Pharma C" or the "Company") announces that on 21 August 2023 it received a written request from one of its shareholders seeking to requisition a General Meeting ("GM") of the Company under section 303 of the Companies Act 2006 (the "Act").  The Directors are currently reviewing the validity of this requisition request with its lawyers and further announcements will be made by the Company in due course following this review.

If the requisition has been validly made in accordance with the Act, a further announcement will be made by the Company relating to the calling of a general meeting and a notice of GM and accompanying circular will posted to shareholders.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

The Directors of Pharma C accept responsibility for this announcement.

END

For additional information please contact:

Pharma C Investments

Gavin Sathianathan, Investment Strategy Director

[e-mail]

Novum Securities (AQSE Corporate Adviser)

Tel: [phone]

David Coffman 

 

END